α52 isn't mobile-compatible yet. It's recommended to use a desktop or laptop.
α52
Alpha 52
Where AI meets Quant
RMD
260.70
+ 0.46%
ResMed Inc.
Healthcare

News Sentiment

48m ago
Bullish 45%
Bearish 55%

News Summary

The company's stock has been trading in a holding pattern around $254 since July 2025, underperforming the broader market's gains. A recent fair value analysis projects its intrinsic value at approximately $258. The company is highlighted as a low-leverage stock, which may offer stability amid industry volatility. Recent third-quarter earnings are seen as a key indicator for the company's near-term direction, prompting analysis on whether the stock is a buy, sell, or hold.
Home Stock Model Insights
Support expand_more